Anti-tumor activity of new artemisinin-chalcone hybrids

Archiv der Pharmazie

Volumn 344, Issue 10, 2011, Pages 639-647

  Xie, Lijun ^a   Zhai, Xin ^a   Liu, Chun ^a   Li, Peng ^a   Li, Yangxiong ^a   Guo, Guoxian ^a   Gong, Ping ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anti tumor activity; Artemisinin; Chalcone; Hybrid

Indexed keywords

10ALPHA AMINODIHYDROARTEMISININ; 10ALPHA AZIDODIHYDROARTEMISININ; 10BETA AMINODIHYDROARTEMISININ; 10BETA AZIDODIHYDROARTEMISININ; ANTINEOPLASTIC AGENT; DIHYDROARTEMISININ; N CHLOROACETYL AMINODIHYDROARTEMISININ; N[4 [3 (2 FLUOROPHENYL) 2 PROPENOYL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 (2 FLUOROPHENYL)2 PROPENOYL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 (2,3 DICHLOROPHENYL) 2 PROPENOYL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 (2,3,4 TRIMETHOXYPHENYL) 2 PROPENOYL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 (2,5 DIMETHOXYPHENYL) 2 PROPENOYL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 (3,4 DIFLUOROPHENYL) 2 PROPENOYL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 (4 CHLORO 2 FLUOROPHENYL) 2 PROPENOYL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 (4 METHYLSULFONYLPHENYL) 2 PROPENOYL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 (4 PYRIDYL) 2 PROPENOYL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 OXO 3 (3 METHOXYPHENYL)PROP 1 EN 1 YL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 OXO 3 (3 PYRIDINYL)PROP 1 EN 1 YL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 OXO 3 (3,4 DICHLOROPHENYL)PROP 1 EN 1 YL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 OXO 3 (4 CHLOROPHENYL)PROP 1 EN 1 YL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 OXO 3 (4 FLUOROPHENYL)PROP 1 EN 1 YL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 OXO 3 (4 TRIFLUOROMETHYLPHENYL)PROP1 EN 1 YL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; N[4 [3 OXO 3 PHENYLPROP 1 EN 1 YL]PHENYLOXYACETYL]AMINODIHYDROARTEMISININ; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ARTEMISININS; CELL LINE, TUMOR; CELL SURVIVAL; CHALCONE; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 80053962923     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201000391     Document Type: Article

References (29)

1. I. K. Mellinghoff, C. L. Sawyers, Pharmacogenomics 2002, 3, 603-623.
2. M. E. Wall, M. C. Wani, Cancer. Res. 1995, 55, 753-760.
3. V. Dhingra, R. K. Vishweshwar, N. M. Lakshmi, Life Sci. 2000, 66, 279-300.
4. T. Efferth, A. Benakis, M. R. Romero, et al,., Free. Radic. Biol. Med. 2004, 37, 998-1009.
5. G. H. Posner, P. Ploypradith, M. H. Parker, et al,., J. Med. Chem. 1999, 42, 4275-4280.
6. S. Cho, Y. Um, J. H. Jung, et al,., Bioorg. Med. Chem. Lett. 2009, 19, 382-385.
7. A. S. Rosenthal, X. C. Chen, J. O. Liu, et al,., J. Med. Chem. 2009, 52, 1198-1203.
8. A. M. Galal, W. Gul, D. Slade, et al., Bioorg. Med. Chem. 2009, 17, 741-751.
9. N. P. Singh, H. Lai, Life. Sci. 2001, 70, 49-56.
10. X. L. Yang, W. Wang, J. Tan, et al., Bioorg. Med. Chem. Lett. 2009, 19, 4385-4388.
11. T. Efferth, Drug. Resist. Update 2005, 8, 85-97.
12. D. Sadava, T. Phillips, S. E. Kane, Cancer. Lett. 2002, 179, 151-156.
13. A. E. Mercer, J. L. Maggs, X. M. Sun, et al., J. Biol. Chem. 2007, 282, 9372-9382.
14. W. Nam, J. Tak, J. K. Ryu, et al., Head Neck 2006, 29, 335-340.
15. H. H. Chen, H. J. Zhou, G. D. Wu, et al., Pharmacology 2004, 71, 1-9.
16. S. Oh, I. H. Jeong, C. M. Ahn, et al., Bioorg. Med. Chem. 2004, 12, 3783-3790.
17. M. Jung, J. Tak, W. Chung, et al., Bioorg. Med. Chem. Lett. 2006, 16, 1227-1230.
18. F. Herencia, M. L. Ferrandiz, A. Ubeda, et al., Bioorg. Med. Chem. Lett. 1998, 8, 1169-1174.
19. S. Ducki, R. Forrest, J. A. Hadfield, et al., Bioorg. Med. Chem. Lett. 1998, 8, 1051-1056.
20. H. Tsuchiya, M. Sato, M. Akagiri, et al., Pharmazie 1994, 49, 756-758.
21. M. L. Go, X. Wu, X. L. Liu, et al., Curr. Med. Chem. 2005, 12, 483-499.
22. M. L. Edwards, D. M. Stemerick, P. S. Sunkara, J. Med. Chem. 1990, 33, 1948-1954.
23. Y. L. Hsu, P. L. Kuo, W. S. Tzeng, et al., Food Chem. Toxicol. 2006, 44, 704-713.
24. O. Nerya, R. Musa, S. Khatib, et al., Phytochemistry 2004, 65, 1389-1395.
25. O. Sabzevari, G. Galati, M. Y. Moridani, et al., Chem. Biol. Interact. 2004, 14, 857-867.
26. K. J. Wallace, R. Hanes, E. Anslyn, et al,., Synthesis 2005, 12, 2080-2083.
27. Y. K. Rao, S. H. Fang, Y. M. Tzeng, Bioorg. Med. Chem. 2004, 12, 2679-2686.
28. L. J. Xie, X. Zhai, J. Zuo, et al., Acta Cryst., E 2010, 66, o1839-o1839.
29. S. Y. Xu, R. L. Bian, X. Chen, Method of Pharmacology, Public Health Publishing House, Beijing 2002, pp. 1784-1786.